November 2014

Recall targets defibrillation electrodes ()
Results in mid-risk patients give next-gen TAVR valve a boost ()
FDA clears noninvasive FFR-CT for assessing blood flow ()
Aggressively managing risk factors improves outcomes after ablations ()
FDG uptake offers clearer picture of high-risk carotid plaque ()
Payment rate on S-ICD set for increase ()
Sister to Sister calls it quits ()
Return to basics in ambulance cardiac arrest care, study suggests ()
ZOLL snaps up Philips’ InnerCool assets ()
Biodegradable DES passes in best-of-class analysis ()
Mortality findings raise more concerns over digoxin's use ()
Key antiplatelet presentation yields more questions than answers ()
Draft report: Jury’s still out on catheter ablation ()
Under statin guidelines, prescriptions rise and testing drops ()
Lombard Medical presents two-year follow-up data from Aorfix PYTHAGORAS pivotal trial at 41st Annual VEITHsymposium ()
Cardioxyl HNO prodrugs show effectiveness in preclinical models following oral administration, improve hemodynamics in chronic diastolic dysfunction ()
Learning from trials ()
New data show dabigatran-specific antidote idarucizumab restores blood clotting mechanism in humans ()
Medtronic studies show cardiac resynchronization therapy extends life, reduces hospital readmissions ()
New data from EVOLVE clinical program demonstrate synergy BioabsoRbable Polymer stent meets key performance endpoints ()
Patients with in-hospital onset STEMI face worse outcomes ()
Out-of-hospital cardiac arrest outcomes improve with increased AED use ()
Cardiac screening of patients with diabetes doesn’t budge outcomes ()
Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa than with warfarin ()
AHA.14: 3D models put hearts in physicians’ hands before surgery ()
Toshiba America Medical Systems Inc. awarded Innovative Technology designation for Dose Tracking System at Novation Innovative Technology Expo ()
MedStar Heart Institute aligns with Cleveland Clinic ()
Four new Pennsylvania facilities join University of Pittsburgh Medical Center East (UPMC East) in receiving ACE accreditation for elective PCI without onsite surgery ()
Real-world data presented at the American Heart Association (AHA) Scientific Sessions underscore hospitalization and outpatient cost-savings for XARELTO compared to standard of care ()
Interim data reinforce safety and effectiveness of Pradaxa (dabigatran etexilate mesylate) versus warfarin in routine care of patients with non-valvular atrial fibrillation ()
AHA.14: EHR method helps define PCI readmission factors ()
ARB offers no benefit over beta-blockers for Marfan’s patients ()
AHA.14 Q&A: Putting DAPT findings in perspective ()
Low-dose aspirin fails to impress in Japanese study ()
Cigna Foundation gives grant to NYU to help minority, senior women with heart disease ()
Mount Sinai study shows vital exhaustion may raise risk of cardiovascular disease ()
The implications of new cholesterol guidelines on a rural Midwest community ()
Fat around the heart may cause irregular heartbeat ()
San Francisco scientist wins AHA Research Achievement Award for ‘transcendent’ findings of blood clot controls leading to new therapy ()
Boston scientist awarded American Heart Association prize for translating bench research into identifiable markers of CVD risk ()
American Heart Association council honors Iowa cardiologist for his distinguished career benefitting physicians and their patients ()
AHA awards Clinical Research Prize to New York cardiologist for leading landmark trials creating guidelines for heart patient care ()
New York medical professor receives AHA Chairman’s Award for leading initiatives on diversity, equity in education and healthcare ()
Pioneer epidemiologist given American Heart Association award for mentoring generations of scientists, doctors and other professionals ()
Mayo Clinic scientist awarded AHA research prize for applying newest technologies to advance diagnosis, treatment of cardiovascular disorders ()
AHA.14: Poor communication impedes efforts to curb atrial fibrillation-related stroke ()
AHA.14: Readmission penalties hit inner-city hospitals hardest ()
AHA.14: N.J.'s mandatory newborn pulse-ox screening shows success ()
AHA.14: PCSK9 inhibitor safe, effective in statin-intolerant patients ()
Cholesterol Care: How Lipid Guidelines Help Tailor Treatment ()
Fixing a Failing Tricuspid Valve from Without ()
Cardiologist, COO, Culture Changer ()
The Continued Growth of Cardio-Oncology Efforts ()
AHA.14: Here's the buzz on second-hand smoke from pot ()
You Snooze, You Lose? Obstructive Sleep Apnea’s Perils & Care ()
Using Logistics to Put AEDs Where They’re Most Needed ()
Yale removes director of cardiovascular research ()
AHA.14: Warfarin plus antiplatelet therapy may raise dementia risk ()
AHA.14: DAPT after one year keeps ischemic risk down ()
Keeping a Careful Eye on Cath Lab Inventory Management ()
Boehringer Ingelheim, WellPoint and HealthCore announce first project under multi-year research collaboration ()
Medtronic study reveals significant heart rhythm disorders occurring in patients undergoing hemodialysis ()
TCT Roundup: From Today’s Triumphs to Tomorrow’s Tech ()
When Rad Is Bad: Reducing Cath Lab Operators’ Exposure Risk ()
Long Shadows Hang Over Sunshine Act ()
Contracts & Payments ()
Seconds Count: Making the Most of Contract Renegotiations ()
American College of Cardiology announces launch of JACC: Electrophysiology ()
Patients perceive spectrum of risk with anticoagulants ()
PCI-capable hospitals accrue 'modestly' higher costs ()
American College of Cardiology joins with 1776 to identify, support health startups ()
Many heart disease patients disregard risks of second-hand smoke ()
AHA’s 16 late-breakers ()
Apps & appropriateness: Cardiac societies put guidelines, AUC at docs' fingertips ()
Referral madness? 75% of specialists get off-target referrals ()
Truven names its top 50 cardiovascular hospitals ()
Recommendations spell out optimal use for left ventriculography ()
From the heart: Gunshot victim, 5, becomes donor ()
Cardio3 snaps up valve access business ()
Robotic catheter ablation may face uphill battle ()
Risk of cardiac death after PCI diminishes after 30 days ()
ACE inhibitors give ALS patients 57% longer symptom-free periods ()
Silk Road Medical announces 30 day results in the Roadster clinical trial for carotid artery revascularization ()
VIVA.14: Promising 1-year results for drug-coated balloons in diabetics ()
Minneapolis Heart Institute Foundation researcher to present at Young Investigators' Forum ()
Medtronic announces Japanese approval and launch of implantable cardioverter-defibrillator system to allow for full-body MRI scans ()
Biotronik settles fraud case for $4.9M ()
VIVA.14: Zilver PTX holds strong at five years ()
Culprit-vessel PCI in STEMI improves outcomes through 1 year ()
40% of patients with atrial fibrillation & stroke discharged with oral anticoagulants ()
Dextran subs for contrast in OCT with similar results ()
VIVA.14: DISRUPT PAD brings lithoplasty technique to peripheral lesions ()
Covidien announces 12-month DEFINITIVE AR results at VIVA 2014 ()
Putting the SGR behind you ()
An extra hospital day lowers readmissions, costs ()
In-hospital cardiac arrest survival carries high readmission rates, price ()
Atrial fibrillation increases risk for asymptomatic brain lesions ()
Treatment periods, fatality rates illuminate DAPT choices ()
Cardinal Health MynxGrip Vascular Closure Device receives Food and Drug Administration approval for venous indication ()
Patients with nonobstructive CAD still at risk for MI, death ()
Covidien’s HawkOne Directional Atherectomy System receives FDA 510(K) clearance for the treatment of peripheral arterial disease ()
Spectranetics offers $30M for PAD balloon ()
CMS final fee schedule offers only crumbs for cardiology ()
Two 2nd-gen drug-eluting stents equally safe, effective at 3 years ()
Cardiovascular Systems receives CE mark for Stealth 360 Peripheral Orbital Atherectomy System ()
Higher risk of bleeds with dabigatran but lower risk of brain hemorrhage ()
Patient-clinician teamwork facilitates performance measure success ()
Medtronic launches Resolute Onyx Drug-Eluting Stent following CE mark ()
Program uses EHR to flag VTE cases in narrative radiology reports ()
Dalteparin outweighs unfractionated heparin in cost savings ()
Heartache or harassment? Cardiologist at center of Yale controversy ()